2010 June 04 |
Biomedical Diagnostics (bmd) obtains the CE mark for its LISA TRACKER Premium kits |
2010 May 06 |
| The LISA TRACKER Premium kits are innovative monitoring tools for the simultaneous assay of TNFα (a cytokine involved in disease progression), anti-TNF therapeutics (Infliximab, Etanercept and Adalimumab) and neutralizing, anti-drug antibodies (ADAs). The correlation of these three parameters is essential for defining and predicting a patient's treatment response. It known that the development of ADAs reduces a treatment's efficacy and induces the long-term resurgence of disease symptoms. In combination with clinical data, the assay results enable physicians to establish the patient's resistance profile and thus optimize the management of certain autoimmune diseases (such as chronic rheumatoid arthritis and ankylosing spondylitis in rheumatology, Crohn's disease and hemorrhagic colitis in gastroenterology and psoriatic arthritis in dermatology). | |
Asuragen Appoints French Distributors Biomedical Diagnostics SA for Signature® |
2010 April 08 |
| Austin, Texas – March 22, 2010. Asuragen, Inc., a leader in the development of molecular diagnostics, announced today the appointment of Biomedical Diagnostics company in Europe, as its exclusive distributor of Signature® Oncology Products in France. Asuragen’s Signature Oncology Portfolio comprises multiplex assays for the detection of mutation in solid and hematologic malignancies. These include a research assay* for KRAS and BRAF mutations, the LTx CE marked IVD assay to detect fusion transcripts in total RNA from whole blood or bone marrow to aid in the clinical diagnosis of translocation positive leukemias, and an assay for the simultaneous detection of the most common NPM1 Mutations*. All these assays utilize multiplex RT-PCR followed by multiplex detection on the Luminex® 100 IS™ or 200™ System. | |
2009 September 09 |
|
|
bmd implements environmentally friendly packaging |
2009 April 21 |
| bmd reagents are now available with a new packaging more environmentally friendly. bmd saves 1.6t of carton per year with a reduction of 30% of the packaging weight. bmd reduces up to 50% of the volume of waste with an easy to compact and recyclable packaging. bmd restricts the quantity of inks with the design simplification. The new packaging meets the quality requirements and makes bmd’s reagents easy to use in laboratories operating conditions: Conservation at 2-8°C and at room temperature, easy to carry and handle packaging. | |
New SeroCT™ RT Kits |
2009 March 26 |
| The serology of Chlamydiae Trachomatis: Easier to use… due to our new Elisa kits Faster manipulation… at room temperature, this technique can be performed on automates Better interpretation… thanks to the cut-off criteria. | |
bmd - OSEO press release |
2008 October 23 |
| Neovacs and BMD announce OSEO Innovation grant of EUR 7.9 million for theranostics project in rheumatoid arthritis. | |
2008 July 28 |
2008 July 15 |
2008 June 10 |
2008 June 10 |
